7-CHLORO-4-FLUORO-1H-INDAZOLE, 95%, 250mg

11-oxo-2,3,5,6,7,11-Hexahydro-1H-pyrano[2,3-f]pyrido[3,2,1-ij]quinoline-10-carboxylic acid, 95.0%, 1g

4-Ethynylcyclohexan-1-one, 97%, 250mg

E-Plan phase EPLPHi S40x/0.65 infinity corrected IOS lens. Working distance 0.78 mm

3-Methoxybenzophenone, 97.0%, 5g

3-(ethoxycarbonyl)-1-(4-ethoxyphenyl)-5-methyl-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 1g

1-(7-Bromo-3,4-dihydroisoquinolin-2(1H)-yl)-2,2,2-trifluoroethanone, 95.0%, 500mg

4-(4-Methoxybenzyl)-3-thiosemicarbazide, 25g

2-(3,4-Dimethoxyphenyl)propanoic acid, 95%, 1g

1-Isopropyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-N-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-1H-indazole-4-carboxamide, 98%, 25mg

4-Chloro-1H-pyrazol-3-ylamine, 95.0%, 100mg

5-Chloro-2-indolizinecarboxylic acid, 500mg

(5-Bromo-3-pyridyl)methanamine dihydrochloride, 97%, 25g